Stepan Company Balances Growth Push With Earnings Pressure

Stepan Company ((SCL)) has held its Q1 earnings call. Read on for the main highlights of the call.

Stepan Company’s latest earnings call painted a mixed picture, blending solid operational momentum in key growth areas with sharp near-term profit pressure. Management struck a cautiously optimistic tone, pointing to strong volume gains in strategic end markets, rising polymer margins and progress on restructuring, even as a large charge, weaker surfactant margins and negative free cash flow weighed on quarterly results.

Record Safety Performance Underpins Operations

Stepan opened the call by underscoring its strongest safety performance on record in the first quarter of 2026. Management framed safety as a core operational pillar, arguing that this culture supports consistent execution across plants and is especially critical as the company ramps new facilities and undertakes major restructuring.

Resilient Organic Sales Growth Despite Macro Pressure

Organic net sales increased 4% year over year, showing the topline can still grow in a sluggish macro environment. Management highlighted this resilience as evidence that underlying demand in many of Stepan’s end markets remains intact, even as some regions and product lines face cyclical and competitive headwinds.

Strategic End Markets Deliver Strong Volume Gains

Overall organic volumes were flat, but the mix was notably favorable with double-digit gains in Crop Productivity, Oilfield and Industrial Cleaning as well as among Tier 2 and Tier 3 customers. Specialty Products volumes jumped 30%, underscoring that Stepan is successfully shifting toward higher-value niches and more diversified customer segments.

Surfactants Sales Up But Margins Under Strain

Surfactants net sales reached $454 million, up 8% on an organic basis as volumes grew 2% and pricing rose roughly 2%, with currency adding about 5%. Volume expanded in all regions except Asia, but profitability lagged because of lower plant absorption, timing issues and volatile oleochemical costs that were difficult to pass through quickly.

Polymers Deliver EBITDA Growth Amid Revenue Decline

Polymer adjusted EBITDA increased 8% year over year despite an 11% decline in net sales, reflecting improved margins and strong North American demand. Growth in Spray Foam and commodity Phthalic Anhydride, along with broader margin recovery, helped offset weak European construction markets and lower volumes in that region.

Specialty Products Expand but Profit Trails Sales

Specialty Products net sales rose 24% to $21 million, powered by a 30% jump in volumes, particularly in the MCT product line. However, adjusted EBITDA for the segment edged down slightly as an unfavorable product mix and delayed raw material cost pass-through kept margins from fully reflecting the strong demand.

Project Catalyst and Balance Sheet Moves Advance

Project Catalyst remains on track to deliver about $100 million of pretax savings over two years, with roughly 60% expected in 2026 and the ramp accelerating from the second quarter. Stepan also agreed to sell nonproductive Millsdale land for $30 million, a move aimed at strengthening the balance sheet while simplifying the asset base.

Pasadena Ramp-Up Supports Future Growth

The Pasadena, Texas facility continues to ramp and is now a focal point of Stepan’s growth strategy in specialty alkoxylates. Management expects the plant to run at roughly 80% utilization on average in 2026 and reach full utilization in 2027, unlocking supply chain savings and supporting higher-margin volume growth.

Shareholder Returns Continue Alongside Deleveraging

Stepan returned $8.9 million to shareholders through dividends in the first quarter and declared a regular quarterly dividend of $0.395 per share. Net debt stood at $511 million with a leverage ratio of 2.7 times, lower than a year ago, which management cited as evidence of ongoing balance sheet discipline and deleveraging progress.

Cash Generation Soft, Free Cash Flow Negative

Cash from operations totaled $17 million in the quarter, but free cash flow was a negative $14 million as seasonal working capital needs weighed. Management characterized the outflow as typical for the first quarter while acknowledging that elevated capital spending keeps near-term cash demands relatively high.

Restructuring Charge Drives Net Loss

Reported results swung to a net loss of $41.4 million, or $1.81 per diluted share, compared with a $19.7 million profit a year earlier. The quarter included a $65.4 million pretax restructuring charge related to site closures and decommissioning, which management framed as a necessary step to streamline the footprint and support long-term profitability.

Adjusted Earnings and EBITDA Under Pressure

Adjusted net income fell 47% to $10.3 million, or $0.45 per diluted share, from $19.3 million a year ago as weaker surfactant earnings and higher interest costs hit the bottom line. Consolidated adjusted EBITDA slipped 14% to $49.6 million, hurt by surfactants and higher unallocated corporate expenses tied to inflation.

Surfactants EBITDA Hit by One-Time and Structural Headwinds

Surfactants adjusted EBITDA fell by $7 million, or 15%, as lower absorption, Asia production timing issues, a U.S. cold snap and competitive pressure in Mexico all took their toll. Elevated and volatile CNO and PKO input costs further squeezed margins, with management indicating that some of these impacts were one-time or timing-related but still significant for the quarter.

European Polymer Weakness Reflects Construction Slump

Polymer net sales declined to $130 million, down 11%, with selling prices off 8% and volumes down 6%, including a double-digit drop in Europe. Management linked the regional weakness to soft construction demand, underscoring that cyclical stress in European building markets remains a drag on this segment.

Capital Spending and Interest Expense Weigh on Cash

Free cash flow was pressured by $31 million of capital expenditures in the quarter, and full-year CapEx is guided to a still-elevated $105 million to $115 million. Interest expense also rose because less interest was capitalized after the Pasadena start-up, cutting into pretax income and further reducing net earnings.

Raw Material and Geopolitical Risks Pressure Margins

Management flagged ongoing raw material inflation and some supply shortages linked to geopolitical tensions that constrained growth in certain lines. These pressures were particularly notable in surfactants, where cost volatility and availability issues are complicating pricing and margin management.

Guidance Emphasizes Savings, EBITDA Growth and Deleveraging

Looking ahead to 2026, Stepan reiterated that Project Catalyst should deliver roughly $100 million in pretax savings over two years, with the majority of the ramp beginning in the second quarter and about 60% of benefits in 2026. The company expects the Pasadena plant to move toward full utilization, adjusted EBITDA to grow, free cash flow to turn positive and leverage to decline even as it maintains CapEx around $105 million to $115 million for the year.

Stepan’s earnings call ultimately balanced confidence in strategic execution against the reality of near-term earnings compression and cash pressure. For investors, the story hinges on whether Project Catalyst savings, Pasadena ramp benefits and strength in targeted end markets can offset surfactant margin challenges, European polymer weakness and persistent inflation over the next several quarters.